|
InfoMedSearch
Medical - Health Information and Search Services
| |
Pain ManagementTreatment is updated daily with the most recent articles listed on top.
|
Pain ManagementGeneral InformationNEWS:ARTICLES:Chronic Pain - Frequently Asked Questions (FAQs) JOURNAL ARTICLES:Cassandra 's curse: Interventional pain management, policy and preserving meaning against a market mentality. (Pain Physician. 2006) Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. (Pain Physician. 2006) "CONCLUSION: Opioid abuse and illicit drug use were common in chronic pain patients with a prevalence of 9% and 16%, respectively. Age, pain after motor vehicle accident, involvement of multiple regions and past history of illicit drug use were identified as risk factors." Diagnosis of acute abdominal pain in older patients. (Am Fam Physician. 2006) "Acute abdominal pain is a common presenting complaint in older patients. Presentation may differ from that of the younger patient and is often complicated by coexistent disease, delays in presentation, and physical and social barriers. The physical examination can be misleadingly benign, even with catastrophic conditions such as abdominal aortic aneurysm rupture and mesenteric ischemia." Differential diagnosis: nociceptive and neuropathic pain. (Am J Manag Care. 2006) How "bad" does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis. (Arthritis Rheum. 2006) "CONCLUSION: These findings suggest that reevaluation of the prescription of pain medication for OA is warranted and that the effectiveness of pain management in OA needs to account for adherence behavior in older adults." Medicare in interventional pain management: A critical analysis. (Pain Physician. 2006) Music for pain relief. (Cochrane Database Syst Rev. 2006) "AUTHORS' CONCLUSIONS: Listening to music reduces pain intensity levels and opioid requirements, but the magnitude of these benefits is small and, therefore, its clinical importance unclear." Pain after discharge: A pilot study of factors associated with pain management and functional status. (J Emerg Nurs. 2006) "DISCUSSION: Patients in this study, on average, continued to experience pain for up to 96 hours after discharge from the emergency department. They reported a high level of pain relief from their ED-prescribed medications. However, interference with functions of daily living due to continued pain was substantial." Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients. (Health Qual Life Outcomes. 2006) "BACKGROUND: Management of pain related to advanced or metastatic cancer, although the availability of several pharmacological and non-pharmacological interventions and the existence of well-known guidelines and protocols, is often difficult and inadequate. Evidence of the relative effectiveness of current options for treating cancer pain from comparative randomized studies is scanty. . Pain afflicts most cancer patients, mainly in the advanced and metastatic phase of the disease [1]. Recent reviews of published literature suggest that the prevalence of pain in advanced cancer is about 70% with ample variations according to the cancer type and disease stage [2]." [Pain therapy in addicted patients.] (chmerz. 2006) "Any addiction is disadvantageous for a successful pain therapy, since some of the prescribed drugs may themselves cause addiction. Drug-dependent patients are often tolerant to opioids. Additionally, there is a risk of iatrogenic pain becoming chronic due to disregard for already known risk factors and comorbidities. However, a history of addiction should not prevent sufficient pain therapy, especially since there is no risk of addiction when the pain therapy employed is adequate for the pathophysiology involved. There are adequate pain therapies for addicted patients." [Pathophysiology of pain.] (Orthopade. 2006) Pelvic pain in the female adolescent patient. (Aust Fam Physician. 2006) Sex differences in adolescent chronic pain and pain-related coping. (Pain. 2006) Strategies for effective postoperative pain management. (Minerva Anestesiol. 2006) Symptoms in the palliative phase of children with cancer. (ediatr Blood Cancer. 2006) "Most frequently mentioned physical symptoms were pain, poor appetite, and fatigue." [The diagnostic dilemma of acute thoracic pain.] (Internist (Berl). 2006) Transdermal opioids for cancer pain. (Health Qual Life Outcomes. 2006)"Patients with moderate to severe malignancy-related pain frequently require the use of opioid pharmacotherapy. Unfortunately, many cancer patients continue to be prescribed subtherapeutic doses of pain medications resulting in undo suffering and diminished quality of life. The choice of analgesic pharmacotherapy should be individualized and based on the intensity and etiology of pain reported by the patient. Health care providers must be able to readily quantify the relative analgesic potency when converting from one opioid to another or from one route of administration to another. Transdermal fentanyl is effective and well tolerated pharmacotherapy for the cancer pain patient. However, clinicians need to be cognizant that the U.S./U.K. manufacturer's recommendations for equilalagesic dosing of transdermal fentanyl may result in initial doses that produce subtherapeutic levels and unrelieved pain in some patients." Use of First- and Second-Generation Cyclooxygenase-2-Selective Nonsteroidal Antiinflammatory Drugs and Risk of Acute Myocardial Infarction. (Circulation. 2006) "BACKGROUND: The cardiovascular safety of cyclooxygenase (COX)-2-selective nonsteroidal antiinflammatory drugs (NSAIDs) has come under scrutiny after the withdrawal of rofecoxib and halting of the Adenoma Prevention with Celecoxib trial. Whether the newer second-generation COX-2 inhibitors (etoricoxib, valdecoxib) also increase the cardiovascular risk is unknown. . CONCLUSIONS: Our study supports the hypothesis that the elevated risk of AMI is a class effect of COX-2 inhibitors. The increase in risk appears to be dose dependent, but further data are needed to verify this observation." What is new in neuropathic pain? (Support Care Cancer. 2006) "CONCLUSION: Drug choices are now based not only on efficacy but also toxicity and drug interactions. For this reason, SNRIs and gabapentin/pregabalin have become popular though efficacy is not better than TCAs. Multiple drug therapies becoming an emergent treatment paradigm research in multiple drug therapy are needed." |
| Privacy Policy | Disclaimer | Research | Suggestions | Subscriptions | Contact Us | |
© 2004-2008, InfoMedSearch, LLC. All rights reserved. | Site design: mqstudio